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Abstract
The global expansion of Chagas disease is due to the constant migration of individu-
als from endemic countries with incidence of vector and nonvector transmission of 
Trypanosoma cruzi. The disease is present in its various stages: chronological character-
istic signs and symptoms of the infection and its mechanism of immune system and 
cell and tissue damage. The first stage, which lasts 90 days approximately, is diagnosed 
by direct methods (blood smears stained with Giemsa, fresh and xenodiagnosis). The 
indeterminate-chronic stage is asymptomatic, but the growth and intracellular binary 
multiplication of the trypomastigotes continue promoting cell lysis and allowing para-
sites to infect other cells, with preferential tropism to organs producing mega syndromes 
such as cardiomyopathy, myocarditis, meningoencephalitis, megaesophagus and mega-
colon. Inadvertently, this process is repeated for several years leading to Chagas disease. 
The mouse inoculation allows checking the parasitemia in vivo and the development 
of the disease in short time (signs, behavior and tropism), histopathological alterations 
and detection of antibodies in serum. These parameters may vary when using different 
strains of T. cruzi from different geographical areas; Triatoma species due to their genetic 
variability are influenced by the environment, nutrition, reservoirs and habitat. The 
murine model ECA CD-1 has the ability to replicate human findings of Chagas disease.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Trypomastigote, Chagas disease, murine model, amastigote, CD-1 strain
1. Introduction
In 1909, the Brazilian doctor and researcher Carlos Ribeiro Justiniano das Chagas discovered the 
etiological agent of the later called Chagas disease in the triatomine insect (family Reduviidae), 
a flagellate protozoan of the genus Trypanosoma and subgenus Schizotrypanum and designated 
the specie adding “cruzi” in honor of his teacher and mentor Oswaldo Cruz, hence the name 
Trypanosoma (Schizotrypanum) cruzi. Later, in 1926, another doctor of Argentine origin, Salvador 
Mazza described the magnitude of the endemy in Argentina, Bolivia and Paraguay, identifying 
the hemoflagellate parasite in blood samples, demonstrating in this way, the existence of the 
trypanosomatida infection, which was given the name of American Trypanosomiasis, since the 
vectors of Trypanosoma cruzi had been found only in America [1].
Chagas disease is a chronic debilitating affectation which impairs the health and the quality 
of life of infected people all around the world. The estimated number of infected people in the 
world arose from 30 million in 1990 to 6–8 million in 2010. In the past 20 years, the annual inci-
dence decreased from 700,000 to 28,000 and the burden of Chagas disease decreased between 
1990 and 2006 from 2.8 million disability-adjusted life to less than half a million [2]. Chagas 
disease is in close relation to the socioeconomic status of the population migration between 
Latin America and the rest of the world, and it currently represents one of the most important 
public health concerns [3]. The initiatives of the Americas have allowed achieving significant 
reductions in the number of acute cases and the presence of domiciliary Triatominae vectors 
in all endemic areas.
Trypanosoma cruzi belongs to the order of the kinetoplastid diseases, a group of parasites 
that has one or two flagella from a monophyletic group that diverged early from the branch 
common to all eukaryotic organisms. The morphological feature that distinguishes them is a 
prominent and paraflagellar structure known as kinetoplast, which corresponds to a conden-
sation of DNA (DNAk), located on the inside of a single mitochondrion, which is branched 
across the cell. Within the family Trypanosomatidae, the Trypanosoma genus is most important 
because it includes a number of human diseases vectors such as T. cruzi, T. brucei gambiense 
and T. brucei rhodesiense, causal agents of Chagas and Sleeping sickness disease, respectively. 
Depending on the behavior of the parasite within the vector, the trypanosome genus has 
been divided into two groups. The first one called stercoraria, includes the trypanosomes 
that develop in the digestive tract of the vector, with the release of the infective forms in the 
stool (T. cruzi and T. lewisi). The second group called Salivaria includes trypanosomes that are 
initially developed in the digestive tube then passing through the epithelium and reaching 
the salivary glands, from where the infective forms are inoculated mechanically by bite or 
sting of the vector (T. brucei, T. congolense and T. rangeli) [4].
1.1. Life cycle
T. cruzi displays a digenetic life cycle alternating its multicellular life between the vertebrate 
host and its invertebrate vector. The cycle starts in the invertebrate arthropod when the 
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insect sucks the blood of an animal carrying trypomastigotes in its blood, which gets to the 
stomach and are transformed into esferomastigotes and the replicative form epimastigotes. 
Subsequently, parasites migrate to the intestine where they multiply and eventually are 
transformed into the infective forms metacyclic trypomastigote, staying in the rectal ampulla 
until they are excreted with feces and urine. In this point, the life cycle continues in humans 
where the highly infective metacyclic forms aim to penetrate the skin or mucous membranes; 
although unable to pass through intact skin, they enter the body through skin or mucous 
membrane abrasions infecting macrophages, fibroblasts, smooth muscle and striated cells, 
Schwann cells, glial cells and neurons, excepting eosinophil and neutrophil cells. Once para-
sites have penetrated the cell, proliferation occurs and the trypomastigotes are released in the 
interior of a parasitophorous vacuole giving rise to amastigotes forms. The life cycle restarts 
with the insect feeding from an infected animal (Figure 1).
1.2. Routes of transmission
We can distinguish three cycles of vector transmission in T. cruzi. The primitive or wild cycle 
is zoonotic in nature. The protozoan parasite circulates between the insect vectors and the 
wild reservoirs (mammals of small and medium size). More than a hundred wild reservoirs 
of T. cruzi among marsupials, xenarthrans, bats, carnivores, lagomorphs, rodents and nonhu-
man primates have been described [6].
Figure 1. Digenetic biological cycle of Trypanosoma cruzi. Adapted by Federico-Mayer Rodolfo† and modified by de 
Diego-Cabrera José Antonio. Faculty of Medicine. Autonomous University of Madrid [5]. Spain, 1984 [5].
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The domestic cycle comprises the infection of humans and the consequent Chagas disease. 
The domestic cycle is defined by factors in the anthroponotic foci, making people one of the 
last natural reservoirs of T. cruzi. Finally, the peridomestic cycle, comprising peridomestic 
mammals (rodents, marsupials, cats and dogs), which are in close contact with humans 
and their residences that have been built invading the habitat of wild triatomas that are 
attracted by the food and the lights of the houses.
Depending on the eco-epidemiological conditions of the place, both circles can overlap 
becoming an intradomiciliary cycle, especially when mankind invades the natural habitat of 
these vectors and builds houses fearing the entrance of reduvids (Figure 2).
On the other hand, the infection transmission by blood transfusion has become a serious com-
plication in nonendemic countries, due to the migration of infected individuals from endemic 
regions [7]. This route is considered the second most important route of transmission in 
endemic areas [8]. T. cruzi resists processes of cryopreservation and thawing and can survive 
up to 18 days in total blood stored at 4°C. The vertical transmission is also known as a natal or 
congenital transmission, including prenatal, perinatal and postnatal care. This mechanism of 
transmission has a variable incidence between 0.1% and 18% according to geographical region 
[9], and has been regarded as the third in order of importance, next to vector-borne and transfu-
sion transmission. An infected mother can transmit the parasite circulating in her blood during 
the second half of gestation. Among infected newborns, only 10–30% present symptoms [10].
The infection is not detected until adulthood in the course of the latent or indeterminate phase 
[11]. Spontaneous abortions have been reported, premature birth, intrauterine growth retar-
dation, stillbirths and various clinical forms that can go from low birth weight, hepatomegaly, 
Figure 2. Exchanges between wild, peridomestic and domestic cycles of T. cruzi transmission. Adapted from Coura and 
Pinto Dias [6].
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splenomegaly, acute respiratory symptoms, anemia, digestive disorders, Cardiac and Central 
Nervous System (CNS). The donation of organs has increased the number of infected people 
in urban areas. It has been informed about the transmission of infection to seronegative 
heart, bone marrow, liver, pancreas and kidney transplant recipients with variable transmis-
sion rates that reach 35% [12]. Patients infected with T. cruzi that should receive a transplant 
also represent a particular challenge, with risk of reactivation of the disease because of the 
immunosuppression after transplantation. The raw meat from infected rats and rabbit can 
be induced by the consumption of foods contaminated with triatomines or its feces, or by the 
ingestion of raw meat from infected mammalian hosts [13]. It must be confirmed by the detec-
tion of the parasites in a direct microscopic examination of a blood sample or other biological 
fluids of the patient. Many cases of numerous outbreaks of acute Chagas Disease are attrib-
uted to oral transmission; it has been detected in the Amazon region, due to the consumption 
of drinks or food contaminated with feces of infected triatomines [14]. It is also important 
to take into account the laboratory accidents that arise when research animals are handled 
mainly by postgraduate students, even though they occur in a smaller proportion [15].
1.3. Pathology and mechanism of injury
The disease presents three phases: the acute, chronic asymptomatic (intermediate or dormant) 
and the chronic symptomatic. The incubation period in the acute phase is 4–10 days and of 
shorter duration when the route of transmission is blood transfusion. This stage is generally 
asymptomatic, or it can occur with systemic manifestations that are common to other diseases 
such as fever, edema, lymphadenopathy, hepatomegaly and splenomegaly. It is accompanied 
by anorexia, fatigue, myalgia, headache and, occasionally, arthralgia. In some cases, there are 
signs of inoculation or entrance door, chagomas, lesions that are more frequent in the face and 
limbs of a forunculoid aspect, pink or violet and indurated borders. A typical sign in children 
is the bipalpebral edema (sign of Roman-Mazza). In this phase, the trypomastigotes are easily 
detected in the blood due to the high parasitemia.
In case the acute phase is overcome, there will be an extended period of chronic disease 
without clinical symptoms that lasts from 5 to 10 years, characterized by low parasitemia 
and by the presence of anti-T. cruzi IgG antibodies. About 30% of seropositive individuals 
reach the chronic phase, and in a span of 10–30 years, clinical manifestations such as heart 
disease and digestive megasyndromes show up, which may occur separately or coexist in 
the same patient. The chronic phase progresses slowly with a predominance of tissue dam-
age. Digestive disorders consist in dilatation of viscera (mainly colon and esophagus, and in 
two-thirds of cases, the progressive myocarditis leads to the development of chronic Chagas 
disease heart (CChC). The relative prevalence of the various clinical manifestations varies 
according to geographic regions. In Argentina, as well as in Venezuela and Central America, 
the main clinical manifestation is the cardiomyopathy. On the contrary, in Chile and in the 
central region of Brazil, the mega syndromes are more frequent. This heterogeneous inci-
dence of manifestations in different endemic areas could obey both biological and genetic 
differences of the circulating parasites [16] and host-related factors (age, gender, ethnicity, 
exposure to infections, family history of Chagas disease heart) [17], in addition to the intro-
duction by migration of infected people from different countries around the world (Figure 3).
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In this last Chagas disease’s phase, histological lesions are disseminated in the heart muscle, 
intestines and nervous system, inflammatory infiltrates composed mainly of CD8+ cells, in 
addition to nests (pseudocysts) full of parasites in their form of amastigotes [18].
Regarding the treatment, there are currently only two drugs available, benznidazole and 
nifurtimox. The therapeutic success is closely related to the stage of infection at the time of 
starting the treatment. Patients in acute phase (regardless of the route of infection), neonates 
and children, have better therapeutic prognosis [12, 15]. On the other hand, the success of 
such drugs is discussed in individuals with chronic infection and so far, there is no estab-
lished therapeutic regimen [19]. The adverse effects are much more important among the 
adult patients; cases of photosensitivity and skin rashes, nausea, anorexia, weight loss and 
abdominal pain have been reported.
Recently, a group of biomedical and clinical scientists members of the network NHEPACHA 
(New Tools for the diagnosis and evaluation of the patient with Chagas disease), based on 
clinical and immunological evidence, have suggested new paradigms regarding the medicines 
for the Chagas disease in order to provide better treatment for patients in chronic phase [20].
On the other hand, the study of biochemical and biological characteristics of the hemofla-
gellate parasite has enabled the identification of new targets for chemotherapeutic agents; 
an example would be the drug trials with inhibitors of the biosynthesis of Ergosterol, 
Posaconazole and Ravuconazole, respectively, in patients with chronic Chagas disease.
1.4. Diagnosis of infection
Parasitological methods for detection of the acute phase have great sensitivity (direct 
methods) [21].
Figure 3. The estimated number of cases of Chagas disease in nonendemic countries, driven by constant migration. 
(ISGlobal, 2015).
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In the same way, these methods are used for the diagnosis of congenital infection in newborns 
and in children under the age of 6 months. The lack of maturation of the immune system and 
the presence of maternal IgG antibodies make, in the latter, the use of the serology for the infec-
tion diagnosis impossible [22]. The protozoan Trypanosoma cruzi is a powerful antigen and a 
few months after the initial inoculation, there is a humoral immune response that is effective 
is controlling the increase of parasitemia, which is mediated by antibodies and enzymes of the 
complement system. There are antibodies to various antigens of T. cruzi (surface, somatic and 
excretion), which belong to different classes (IgG, IgA, IgM) and subclasses [23–25]. The sero-
logic test for the selection of blood donors must conform to the Official Mexican Standard for 
Epidemiological Surveillance, Prevention and Control of Vector-borne Diseases [26–28], citing 
that it must analyze the serum of each donor with two conventional immunological tests; if 
one of them is reactive, a third one will be carried on in such a way so as to qualify the donor as 
either positive or negative, with two reactive or two negative tests. In all cases, the laboratory 
diagnosis should be accompanied with epidemiological and clinical history of the patient, as 
the current and past source, the type of housing where it is found, the trips that could have 
been made to endemic areas and the history of blood transfusions and the infected mother.
1.5. Origin of the discrete units (UDTs) typing of Trypanosoma cruzi
The evolutionary history of T. cruzi infection is closely related to its vertebrate host [29]. The 
mammal fauna of South America in the cretaceous period mainly consisted of marsupials and 
Figure 4. Geographic distribution of Trypanosoma cruzi, subpopulations disease phases with the corresponding primary 
clinical manifestations.
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placentals, the ancestral of the order Xenarthra (armadillos, anteaters and sloths), which were 
the natural reservoirs of the parasite at the time. The various ecotopes in whom were these two 
groups of hosts would have made possible the evolution by clonal propagation of two groups of 
parasites, which gave rise to the ancestral UDTs, TcI and TcII. It has been suggested that 1Cwi, 
evolved in association with the marsupial mammals of the genus Didelphis (weasels) and T. cruzi 
II, did in relation to the terrestrial mammals, such as armadillos [30]. Trypanosoma cruzi is a spe-
cies composed of heterogeneous populations that circulate in nature between human beings, 
arthropod vectors, domestic animals, and wild reservoirs [31]. Currently, it is generally accepted 
that T. cruzi is a paradigmatic pattern of clonal evolution with low rate of gene recombination. A 
constant pattern of T. cruzi, behavior cannot be expected since different strains (subpopulations) 
circulate in nature. Extensive polymorphism promotes variation in infecting capacity, behavior 
in different hosts (virulence, histotropism, curves of parasitemia), adaptation to different vec-
tors, immune response, stimulation, susceptibility to different chemical compounds, capacity 
of replication and differentiation, among others. Subpopulations are currently identified in the 
laboratory by biochemical, immunological and molecular biology assays [32, 33] (Figure 4).
Studies in murine experimental models have shown that both the parasite and host genotypes 
are crucial for tissue distribution and pathophysiology of infection by T. cruzi [34]. It has been 
previously reported that 81% of the Mexican strains of T. cruzi belong to lineage TcI and have 
different capabilities of infection, virulence and processing capacity in vitro, when compared 
to the other lineages [35, 36] (Figure 5).
2. Importance of the murine model in research American 
trypanosomiasis
2.1. The murine model in biomedical research
Animal models are very useful for studying human diseases because there are hundreds of 
pathogens that affect both humans and animals. The use of experimental animals in biomedical 
Figure 5. Distribution of Trypanosoma cruzi strains in México [35, 36].
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research represents a key element for development of new prevention approaches and treatment 
of transmissible and nontransmissible diseases. Suffice it to recall the rabies vaccines, smallpox, 
tetanus, diphtheria, whooping cough and polio, the development of several antibiotics, insulin, 
and the knowledge of the genetic bases of inheritance [37]. No doubt that mice are the most com-
monly used animal for in vivo assays among experimental animal models in biology and medi-
cine. The use of mice allows the study of mammal’s reactions against aggressions like poisoning 
or infection (viral, bacterial, or parasitic), the study of immune responses and disorders and 
many others in several different fields like oncology, teratology and embryology [38] (Figure 6).
Herein, we present a comparative cross-sectional study involving four Trypanosoma cruzi strains 
obtained from three different species of triatomas captured in endemic areas of the states of Jalisco 
(T. longipennis), Morelos (T. palidipennis), Nayarit(T. longipennis) and Queretaro (T. Mexicana)
2.2. Collection sites
Several communities from different States of México were included in the present study: San 
Pablo, Tolimán in Querétaro State, Milpillas of Talpa de Allende in Jalisco State, Sant Catarina 
in Morelos State and Jala in Nayarit State (Figure 7).
2.3. Triatoma collection and maintenance
Cages covered with adhesive tape were used, with the glue facing outward. A live Wistar rat 
was placed inside the cage. Cages were placed at late night in strategic areas under the loose 
stones of poultry and farm animal fences, fallen leaves and wooden logs. Cages were collected 
the next day, early in the morning (Figure 8).
Triatomas glued to the surface of the gummed paper were carefully detached, with the aid 
of entomological tweezers and placed in jars covered with mosquito mesh. A piece of filter 
paper in accordion shape was placed inside the bottle to facilitate the movement of the triato-
mas and the collection of urine or feces deposited on its surface.
The triatomas are maintained inside the bottles at 25–26°C and 60% humidity (RH) in bacte-
riological incubator. Triatomas were blood fed directly from a shaved rabbit every 2 weeks 
allowing them to feed for 20–25 m and then they were placed back in the incubator (Figure 9).
2.4. Study of the intestinal content in the triatomine
We use two techniques for collecting intestinal content from triatomine after blood feeding. 
In the first one, the triatomine is introduced in a 10 x 20 mm tube; normally the bug deposits 
Figure 6. The laboratory animal is “any specie of animal that is kept under certain conditions and is used for scientific 
purposes” [37, 39].
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stool or urine in the bottom of the tube and then it is collected with saline solution. The second 
technique consists in pressing gently the triatomine abdomen, inducing that the rectal blister 
freely releases the stool (semi-separated blood). Intestinal content is collected in a watch glass 
and saline solution is added at 37°C. In both techniques, the metacyclic trypomastigote and 
epimastigote forms are observed fresh, using a microscope with 400 magnifications. The try-
pomastigotes are counted in a Neubauer chamber. If the count is above 10,000 parasites per 
cubic centimeter, mice are inoculated as mentioned below.
The same procedure is performed with each one of the strains of species of triatomas captured 
(Figure 10).
2.5. Trypanosoma cruzi, inoculation in mice
Male mice of CD-1 strain are used since estrogen in females can stimulate the activity of 
macrophage phagocytes and, the localized immune response [38].
Using an insulin syringe four groups of 10 mice were inoculated intraperitoneally with 3x103 
epimastigote and/or trypomastigote forms of Trypanosoma cruzi, isolated from four species of 
Figure 8. Traps are placed in the collection site (A). Cage with triatomas stuck to the adhesive tape (B) Photos. 
Villagrán-Herrera.
Figure 7. Map of the Mexican Republic. The black stars indicate the capture zones of the triatomas, used in our 
investigation.
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triatomas (T. mexicana, T. pallidipennis, T. longipennis and T. dimidiata). Mice from the control 
group were inoculated with saline solution.
2.6. Study of behavior (signs)
After the first day of inoculation, the behavior of the infected murine model was observed, 
comparing it with an uninfected control.
2.7. Study of the parasitemia
Parasitemia levels are determined in infected mice 5,10,15,20,25 and 30 days post T. cruzi 
inoculation. Blood is obtained from the distal part of the queue 1:4000 EDTA is used as anti-
coagulant, in a pipette of leukocyte count. Numbers of parasites per milliliter are calculated 
from sample observations in Neubauer chamber [37, 38].
2.8. Histopathological analysis
Histological sections of 10 microns are obtained from mouse dissected organs (brain, heart, 
intestines and skeletal muscle) and stained with H/E. Microscope slide preparations are 
Figure 9. A and B. Transportation and storage of collected triatomas. Photos Villagrán Herrera.
Figure 10. Tube techniques to obtain stool from the Triatoma (10A). Fourth stage Triatoma nymphs feeding on a rabbit. 
Photos Villagrán-Herrera.
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observed at 40X [39]. Tissues from infected mice and the respective control animals are 
included in the analysis.
2.9. Detection of antibodies in serum (detection of anti-Trypanosoma cruzi 
antibodies in serum)
Blood is obtained by cardiac puncture and centrifuged at 5000 rpm to separate the clot from 
the serum and maintained at −20°C until it is used to carry out an ELISA (Accutrack Chagas 
Microelisa Test) in the search of anti-Trypanosoma cruzi antibodies.
3. Results
The mice inoculated with all the studied T. cruzi strains showed an altered behavior when 
compared to control animals. The signs presented 24 h post T. cruzi inoculation, the mice 
exhibited hyperactivity, the hair was dull and bristled, the hind legs became intertwined, and 
it began to drag them away, with great difficulty in moving forward.
However, it was possible to observe some differences in the virulence of each strain according 
to the geographic area geographic area where they came from (Figure 11).
The inoculant obtained from triatomines from Talpa de Allende in Jalisco state and Santa 
Catarina in Morelos state generated in the corresponding mice a parasitemia of 3: 4 try-
panosomes per field, at 14 and 16 days postinoculation, respectively. In both cases, altered 
movements and physical shape of the mice began at about the same time. By day 20 and 23, 
respectively, the parasitemia reached the peak, so it was proceeded to sample fresh blood and 
dissect organs in order to perform the serological and histopathological assays
Parasitemia in mice inoculated with the Trypanosoma cruzi from triatomines caught in Jala, in 
Nayarit State reached the peak 30 days post inoculation. It was possible to detect anti-T. cruzi 
antibodies in 2 mice out of 10 by conventional ELISA test.
Blood parasitemia was undetectable in mice inoculated with T. cruzi strains obtained from 
triatomines collected in San Pablo and Tolimán in Querétaro State. The animal behavior was 
Figure 11. T. cruzi infected mice exhibiting hyperactivity, dull and bristled hair and intertwined hind legs. (11A and 11B). 
Photos Villagran Herrera.
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completely normal when comparing to control group. Organs looked slightly bigger, mainly 
the intestines and heart. It was possible to detect anti-T. cruzi antibodies in the serum. Results 
are summarized in Table 1.
Geogra-
phic area
Species of 
Triatoma
Days in 
which 
presents 
parasitemia
Frizz 
hair
Difficulty 
walking
ELISA 
test
Brain Heart Skeletal 
muscle
Intestine
Talpa de 
Allende. 
Jalisco
T. longi- 
pennis
14 Positive Positive Reactive Negative Positive Positive
+++
Negative
Jala
Nayarit
T. dimidiata 30 Positive Negative Reactive Negative Negative Positive 
++
Negative
San 
Pablo 
Tolimán
Qro.
T. mexicana It was 
presented 
in 90 days
Negative Negative Reactive Negative Negative Negative Negative
Sta. 
Catarina
Morelos
T. 
pallidipennis
16 Positive Positive Reactive Negative Positive Positive++ Negative
Table 1. Results of the behavior, parasitemia, serology and histology in the murine model, infected with inoculum of 
four strains of Trypanosoma cruzi, isolated from triatomas captured in different geographical areas.
Figure 12. Histopathological analysis of cardiac (A, B) and intestine muscle (C, D) tissues. A and C, control groups. 
B, cardiac tissue with pseudocysts with high parasitemia and formation of new agglomerations of amastigotes, Jalisco 
strain. D, intestine muscle tissue with a mild T. cruzi parasitemia, Nayarit strain. Photos Villagran-Herrera.
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Presence of amastigote nests and histopathological damage in heart and intestine muscle 
showed direct relationship with parasitemia level, which indicates that trypanosomes are 
installed and recognize different tissues where they reproduce rapidly intracellularly, result-
ing in a greater number of parasites in blood after they differentiate into trypomastigotes. This 
sequence is only observed in the most virulent strains such as those from the States of Jalisco, 
Morelos and Nayarit (Figure 12).
4. Conclusions
In the present study, assessment of clinical manifestations, parasitemia levels, histo-
logical changes and seropositivity in murine model allowed us to know the behavior of 
different T. cruzi strains found in triatomas from different geographic areas in Mexico. 
This confirms the existence of genetically different strains that produce a complex called 
“cruzi” from the pathognomonic and morphophysiological point of view, as previously 
reported [40].
T. cruzi infection depends on genotype of both the parasite and the mammalian host, which in 
turn influences tissue tropism and the pathophysiology of infection.
We were able to identify two different T. cruzi strains (Tc I) from triatomines from two 
communities from Queretaro State that exhibited mild virulence when compared to other 
three strains from triatomines from three different States in México. Isozyme character-
ization waits to be carried out in order to explain if those observed differences might be 
attributable to the fact that different species of blood-sucking triatomine insects were 
used [40].
5. Discussion
Mitie-Nisimura et al., in 2014, were able to induce acute phase inoculating mice by intra-
peritoneal injection trypomastigote forms of T. cruzi. Authors observed the microvascular 
alterations and oxidative stress in the brain and the formation of pseudocysts full of 
amastigotes in the heart muscle [41]. Espinoza et al., in 2010 inoculated Balb/c mice with 
two strains of T. cruzi I (Tc I) isolated from patients in Mexico in order to study the 
immune response [35]. The first case of clinical infection with T. cruzi was reported in 
a horse in South Texas in 2015, observing forms of amastigotes in the spinal cord and 
cardiac tissue.
Espinoza et al., in 2010, observed contrasting differences between two T. cruzi strains iso-
lated from Triatoma barberi and Triatoma mexicana. In the first case, virulence was clearly 
observed while in the second one, productive infection and morphological alterations were 
not observed, and only the anti-T. cruzi antibodies were detected.
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